Replimune Limited
- Company number
- 09496393
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 18 Mar 2015
- Nature of business
- Research and experimental development on biotechnology
Registered office
Officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| JORDAN COMPANY SECRETARIES LIMITED | Corporate-Secretary | 18 Mar 2015 | 7 May 2015 |
| BOORSMA, Marco, Dr | Director | 8 May 2015 | 16 Sep 2015 |
| LIM, Richard | Director | 8 May 2015 | 16 Sep 2015 |
| RHODES, Jason Paul | Director | 16 Sep 2015 | 10 Jul 2017 |
| SLOOTWEG, Hugo Alexander | Director | 8 May 2015 | 10 Jul 2017 |
| STAMPACCHIA, Otello | Director | 8 May 2015 | 10 Jul 2017 |
| COFFIN, Robert Stuart, Dr | Director | 18 Mar 2015 | 10 Jul 2017 |
| LOVE, Colin | Director | 10 Jul 2017 | 4 Oct 2024 |
| ASTLEY-SPARKE, Philip | Director | 18 Mar 2015 | 4 Oct 2024 |
| GLIDDEN, Shawn | Director | 4 Oct 2024 | |
| PATEL, Sushil | Director | 4 Oct 2024 | |
| HILL, Emily | Director | 4 Oct 2024 |
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Replimune Group, Inc. | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
23 Jul 2018 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Mar 2026 | £10,874,053 | £4,439,720 | 68 |
| 31 Mar 2025 | £9,958,411 | £2,393,424 | 65 |
| 31 Mar 2024 | £10,677,474 | £1,752,703 | 53 |
| 31 Mar 2023 | £9,157,359 | £1,158,085 | 51 |
| 31 Mar 2022 | £10,431,017 | £4,627,320 | 49 |
| 31 Mar 2021 | - | - | - |
| 31 Mar 2020 | £6,552,043 | £3,136,447 | 32 |
| 31 Mar 2019 | £5,341,686 | £2,706,601 | 26 |
| 31 Mar 2018 | £13,160,992 | £7,344,171 | 15 |
| 31 Mar 2017 | £20,502,254 | £15,914,520 | 3 |
| 31 Mar 2016 | - | - | - |